Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension

European Respiratory Journal

Volumn 15, Issue 4, 2000, Pages 640-648

  Kim, H ^b,c   Yung, G L ^a   Marsh, J J ^a   Konopka, R G ^a   Pedersen, C A ^a   Chiles, P G ^a   Morris, T A ^a   Channick, R N ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Bosentan; Chronic thromboembolic pulmonary; Hypertension; Immunohistochemistry; Morphometry; Postobstructive pulmonary vasculopathy

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; CONTROLLED STUDY; DOG; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MORPHOGENESIS; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RECEPTOR BLOCKING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELIN-1; FEMALE; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; MALE; PROBABILITY; PULMONARY ARTERY; PULMONARY CIRCULATION; PULMONARY EMBOLISM; REFERENCE VALUES; SULFONAMIDES; TOMOGRAPHY, EMISSION-COMPUTED; VASCULAR RESISTANCE;

EID: 0034129331     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15d04.x     Document Type: Article

References (32)

1. Moser KM, Auger WA, Fedullo PF. Chronic major vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735-1741.
2. Moser KM, Auger WA, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992; 5:334-342.
3. Fedullo PF, Auger WR, Channick RN, Moser KM, Janieson SW. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 1995; 16: 353-374.
4. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103: 685-692.
5. Hirsch AM, Moser KM, Auger WR, Channick RN, Fedullo PF. Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? Am J Respir Crit Care Med 1996; 154: 491-496.
6. Yanagisawa M. The endothelin system: a new target for therapeutic intervention. Circulation 1994; 89:1320-1322.
7. Arai H, Hori H, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732.
8. Barnes PJ, Liu SF. Regulation of pulmonary vascular tone. Pharmacol Rev 1995; 47: 87-131.
9. Ferro CJ, Webb DJ. The clinical potential of endothelin receptor antagonists in cardiovascular medicine. Drugs 1996; 51: 12-27.
10. Tamirasa P, Frishman WH, Kumar A. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am Heart J 1995; 130: 601-610.
11. Giaid AG, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328: 1732-1739.
12. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Int Med 1991; 114: 464-469.
13. Yamakami T, Taguchi O, Gabazza EC, et al. Arterial endothlin-1 level in pulmonary emphysema and interstitial lung disease: relation with pulmonary hypertension during exercise. Eur Respir J 1997; 10: 2055-2060.
14. Oparil S, Chen SJ, Meng QCElton TSYano MChen Y. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am J Physiol 1995; 268: L95-L100.
15. Eddahibi S, Raffestin B, Clozel M, Levame M, Adnot S. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol 1995; 268: H828-H835.
16. Okada M, Yamashita C, Okada K. Endothelin receptor antagonists in a beagle model of pulmonary hypertension: contribution to possible potential therapy? J Am Coll Cardiol 1995; 25: 1213-1217.
17. Moser KM, Cantor JP, Olman M, et al. Chronic pulmonary thromboemboliism in dogs treated with tranexamic acid. Circulation 1991; 83: 1371-1379.
18. Cantor JP, Graif JL, Konopka RG, Hartman MT, Moser KM. Chronic pulmonary thromboembolism in canines treated with tranexamic acid. Am Rev Respir Dis 1988; 137: 185A.
19. Fernie J, Lamb D. New method for measuring intimal component of pulmonary arteries. J Clin Pathol 1985; 38: 1374-1379.
20. Fernie J, Lamb D. New method for quantitating the medial component of pulmonary arteries. Arch Pathol Lab Med 1985; 109: 843-848.
21. Davies P, Reid L, deMello D. Methods in experimental pathology of pulmonary vasculature. In : Gil J, eds. Models of Lung Disease. 1st Edn New York, NY, USA, Marcel Dekker, 1990; pp. 843-904.
22. Hsu S, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981; 75: 734-738.
23. Hislop A, Reid L. Changes in the pulmonary arteries of the rat during recovery from hypoxiainduced pulmonary hypertension. Br J Exp Pathol 1977; 58: 653-662.
24. Li H, Elton TS, Chen YF, Oparil S. Increased endothelin receptor gene expression in hypoxic rat lung. Am J Physiol 1994; 266: L553-L601.
25. Chen S, Chen Y, Meng QC, Durand J, Dicarlo VS, Opraril S. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 1995; 79: 2122-2131.
26. Miyauchi T, Yorikane R, Sakai S, et al. Contribution of endogenous endothelin-1 to the progression of cardio-pulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993; 73: 887-897.
27. Wong J, Reddy VM, Hendricks-Munoz K, Liddicoat JR, Gerrets R, Fineman JR. Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 1995; 269: H1965-H1972.
28. Zamora MR, Stelzner TJ, Webb S, Panos RJ, Ruff LJ, Dempsey EC. Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol 1996; 270: L101-L109.
29. Stelzner TJ, O'Brien RF, Yanagisawa M, et al. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol 1992; 262: L614-L620.
30. Michel RP, Hakim TS, Petsikas D. Segmental vascular resistance in postobstructive pulmonary vasculopathy. J Appl Physiol 1990; 69: 1022-1032.
31. Michel RP, Hakim TS. Increased resistance in postobstructive pulmonary vasculopathy: structure-function relationships. J Appl Physiol 1991; 71: 601-610.
32. Giaid A, Stewart DJ, Michel RP. Endothelin-1-like immunoreactivity in postobstructive pulmonary vasculopathy. J Vasc Res 1993; 30: 333-338.